compounded semaglutide with niacinamide – $149/mo Semaglutide Microdose | GoodGirlRx

Potential side effects include nausea, constipation, and gastrointestinal discomfort, particularly during early dose escalation

This is not a dilution strategy

For browsing related education, the Type 2 Diabetes category lists additional articles on diabetes care topics

Retatrutide is an investigational drug and is not FDA-approved as of April 2026

[2] Mazdutides phase II trial in adults with obesity or excess weight showed approximately 10-14% weight loss at 4 mg and 6 mg doses over 32 to 48 weeks, with ongoing phase III trials investigating higher doses and effects on type 2 diabetes

Pathway two: BMI of 27 or higher with at least one weight-related comorbidity